Pipeline Watch: Enhertu, Velexbru, Viltepso Approvals
Numerous Trials Paused Due To COVID-19
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.